These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30864193)

  • 1. Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.
    Meissner JE; Korzowski A; Regnery S; Goerke S; Breitling J; Floca RO; Debus J; Schlemmer HP; Ladd ME; Bachert P; Adeberg S; Paech D
    J Magn Reson Imaging; 2019 Oct; 50(4):1268-1277. PubMed ID: 30864193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
    Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
    J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
    Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
    Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.
    Zaiss M; Windschuh J; Goerke S; Paech D; Meissner JE; Burth S; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Ladd ME; Bachert P; Radbruch A
    Magn Reson Med; 2017 Jan; 77(1):196-208. PubMed ID: 26845067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.
    Yuwen Zhou I; Wang E; Cheung JS; Lu D; Ji Y; Zhang X; Fulci G; Sun PZ
    Magn Reson Med; 2017 Dec; 78(6):2307-2314. PubMed ID: 29030880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy in the quantification of chemical exchange saturation transfer (CEST) and relayed nuclear Overhauser enhancement (rNOE) saturation transfer effects.
    Zhang XY; Wang F; Li H; Xu J; Gochberg DF; Gore JC; Zu Z
    NMR Biomed; 2017 Jul; 30(7):. PubMed ID: 28272761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T.
    Xu X; Yadav NN; Zeng H; Jones CK; Zhou J; van Zijl PC; Xu J
    Magn Reson Med; 2016 Jan; 75(1):88-96. PubMed ID: 26445350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T.
    Goerke S; Soehngen Y; Deshmane A; Zaiss M; Breitling J; Boyd PS; Herz K; Zimmermann F; Klika KD; Schlemmer HP; Paech D; Ladd ME; Bachert P
    Magn Reson Med; 2019 Aug; 82(2):622-632. PubMed ID: 30927313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
    Wu Y; Chen Y; Zhao Y; Yang S; Zhao J; Zhou J; Chen Z; Sun PZ; Zheng H
    Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
    Kroh F; von Knebel Doeberitz N; Breitling J; Maksimovic S; König L; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
    Magn Reson Med; 2023 Oct; 90(4):1569-1581. PubMed ID: 37317562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.
    von Knebel Doeberitz N; Kroh F; Breitling J; König L; Maksimovic S; Graß S; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
    Radiother Oncol; 2023 Jul; 184():109694. PubMed ID: 37150450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
    Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
    J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
    Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical routine acquisition protocol for 3D relaxation-compensated APT and rNOE CEST-MRI of the human brain at 3T.
    Goerke S; Breitling J; Korzowski A; Paech D; Zaiss M; Schlemmer HP; Ladd ME; Bachert P
    Magn Reson Med; 2021 Jul; 86(1):393-404. PubMed ID: 33586217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
    Regnery S; Adeberg S; Dreher C; Oberhollenzer J; Meissner JE; Goerke S; Windschuh J; Deike-Hofmann K; Bickelhaupt S; Zaiss M; Radbruch A; Bendszus M; Wick W; Unterberg A; Rieken S; Debus J; Bachert P; Ladd M; Schlemmer HP; Paech D
    Oncotarget; 2018 Jun; 9(47):28772-28783. PubMed ID: 29983895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
    Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
    Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
    Debnath A; Gupta RK; Singh A
    Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of amide proton transfer effect and relayed nuclear Overhauser enhancement effect at -3.5ppm using CEST with double saturation powers.
    Zhao Y; Sun C; Zu Z
    Magn Reson Med; 2023 Sep; 90(3):1025-1040. PubMed ID: 37154382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.